Efficacy and Safety of Lobaplatin and Carboplatin as Neoadjuvant Therapy in HER-2 Positive Breast Cancer
Clinical trial NCT07093931 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07093931
- Sponsor
- Shandong Cancer Hospital and Institute
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2025-08-01
- Primary completion
- 2027-08-01
- Enrollment
- 468
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.